This diagnostic procedure analyzes a urine sample for the presence of nine specific substances. These substances are typically drugs or drug metabolites, providing information about recent substance use. The analysis can identify commonly abused substances, including opioids, cannabinoids, amphetamines, and cocaine, among others. The specific panel configuration may vary slightly depending on the testing laboratory and the intended purpose, but it consistently covers a pre-defined set of compounds.
Its utility lies in its ability to detect substance use that may be relevant in various contexts. In healthcare settings, it can aid in diagnosis and treatment planning. In employment scenarios, it is often used for pre-employment screening or maintaining a drug-free workplace. Legal and forensic applications also benefit from its accuracy and relative ease of administration. The practice provides valuable insights into patterns of substance abuse, informing public health initiatives and contributing to individual well-being through appropriate intervention and support.